Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan in adults with a systemic right ventricle
NL-OMON21444Phase 3Withdrawn
- Sponsor
- Amsterdam University Medical Center
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in transposition of the great arteries (TGA) and congenitally corrected transposition of the great arteries (ccTGA) comparing Valsartan with Placebo (2 arms). Primary endpoint: Change in right ventricular ejection fraction. Planned start Aug 2006; status: withdrawn.
02
Drugs
valsartan
03
Conditions
transposition of the great arteries (TGA)congenitally corrected transposition of the great arteries (ccTGA)
Beyond the preview
Go deeper on NL-OMON21444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21444.